[Diabetes Infobus 1999. General facts].
In Austria in 1999, a Diabetes screening program was carried out by the Austrian Diabetes Association and by Novo Nordisk and Roche Diagnostics with a special equipped bus touring through more than 90 cities. The population was invited to a screening of blood glucose (random), blood pressure, body weight und serum-cholesterol. The diabetes risk was evaluated by history and familiar burden with a questionnaire. The results were handed over to the visitors and their general practitioners, and a copy was used for anonymously analysis.
Zauner
W
W
Forschungsabteilung, Novo Nordisk Pharma GesmbH, Erdbergstrasse 52-60, A-1030 Wien. wzau@novonordisk.com
D000328:Adult; D000368:Aged; D001317:Austria / Q000453:epidemiology; D001786:Blood Glucose / Q000378:metabolism; D001795:Blood Pressure Determination / Q000706:statistics & numerical data; D001835:Body Weight; D002784:Cholesterol / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*; D005260:Female; D006266:Health Education / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000706:statistics & numerical data*; D008875:Middle Aged; D008952:Mobile Health Units / Q000706:statistics & numerical data*; D012307:Risk Factors
D001786:Blood Glucose; D002784:Cholesterol